Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Droller

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Urology|July 24, 2002
Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapyMichael J Droller
The Journal of Urology|October 24, 2002
A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive resultsMichael J Droller
The Journal of Urology|October 31, 2002
Prognostic value of p53 overexpression in T1G3 bladder tumours treated with bacillus Calmette-Guérin therapyMichael J Droller
The Journal of Urology|October 31, 2002
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VACMichael J Droller
The Canadian Journal of Urology|October 6, 2016
Legends in UrologyMichael J Droller
The Journal of Urology|November 7, 2003
Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory)Michael J Droller
Urologic Oncology|March 17, 2009
Promoting surgeon-scientists in urologic oncology: The role of our journalMichael J Droller
The Journal of Urology|September 18, 2007
Urologic cancer--when is less more?Michael J Droller
The Medical Clinics of North America|November 25, 2010
Preface urologic issues for the internistMichael J Droller
The Journal of Urology|December 25, 2016
Intracavitary bacillus Calmette-Guérin for Superficial Bladder TumorsMichael J Droller
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Urology|July 24, 2002
Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapyMichael J Droller
The Journal of Urology|October 24, 2002
A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive resultsMichael J Droller
The Journal of Urology|October 31, 2002
Prognostic value of p53 overexpression in T1G3 bladder tumours treated with bacillus Calmette-Guérin therapyMichael J Droller
The Journal of Urology|October 31, 2002
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VACMichael J Droller
The Canadian Journal of Urology|October 6, 2016
Legends in UrologyMichael J Droller
The Journal of Urology|November 7, 2003
Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory)Michael J Droller
Urologic Oncology|March 17, 2009
Promoting surgeon-scientists in urologic oncology: The role of our journalMichael J Droller
The Journal of Urology|September 18, 2007
Urologic cancer--when is less more?Michael J Droller
The Medical Clinics of North America|November 25, 2010
Preface urologic issues for the internistMichael J Droller
The Journal of Urology|December 25, 2016
Intracavitary bacillus Calmette-Guérin for Superficial Bladder TumorsMichael J Droller
Pageof 8